Granules acquires Swiss firm for Rs 192 cr; forays into CDMO space

Granules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acquisition, expected to complete by mid-2025, aims to leverage Senn's peptide synthesis expertise with Granules' large-scale manufacturing capabilities to deliver high-quality peptide-based solutions globally.